Vosoritide for Selected Genetic Causes of Short Stature
Clinical trial NCT04219007 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04219007
- Sponsor
- Andrew Dauber
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-08-04
- Primary completion
- 2025-08-14
- Enrollment
- 56
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.